Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,835Open textbooks209Open-access articles1,406Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology182Genetics and Genomics170Neuroscience185Cardiovascular Medicine180Immunology142Pharmacology173Molecular Biology161Infectious Diseases150Rare and Inherited Diseases181Clinical Research173Anatomy and Physiology613Drugs and Chemicals621Psychiatry and Psychology185Public Health and Nutrition178Diagnostics and Medical Technology125Respiratory Medicine113Digestive System and Liver91Metabolism and Endocrine Disease177Bones, Joints, Muscles and Skin213Kidney, Urology and Women's Health173Eye, Ear, Nose and Throat55
Plans & pricingCompare EvidenceHelix workspace plans
Library›Open textbooks›Medical management and intervention (using neurosurgical resection or stereotactic radiosurgery) versus medical management alone for symptomatic brain cavernoma: the CARE pilot RCT›References

Continue where you left off ()

Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Medical management and intervention (using neurosurgical resection or stereotactic radiosurgery) versus medical management alone for symptomatic brain cavernoma: the CARE pilot RCT · References

References

CC BY 4.0 · National Institute for Health and Care Research · approximately 8 min read

  1. Loan JJM, Bacon A, van Beijnum J, Bhatt P, Bjornson A, Broomes N, et al. Feasibility of comparing medical management and surgery (with neurosurgery or stereotactic radiosurgery) with medical management alone in people with symptomatic brain cavernoma – protocol for the cavernomas: a randomised effectiveness (CARE) pilot trial. BMJ Open 2023;13:e075187. 10.1136/bmjopen-2023-075187
  2. Morris Z, Whiteley WN, Longstreth WT Jr, Weber F, Lee YC, Tsushima Y, et al. Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2009;339:b3016.19687093
  3. Al-Shahi Salman R, Berg MJ, Morrison L, Awad IA; Angioma Alliance Scientific Advisory Board. Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Stroke 2008;39:3222–30.18974380
  4. Al-Shahi R, Bhattacharya JJ, Currie DG, Papanastassiou V, Ritchie V, Roberts RC, et al.; Scottish Intracranial Vascular Malformation Study Collaborators. Prospective, population-based detection of intracranial vascular malformations in adults: the Scottish Intracranial Vascular Malformation Study (SIVMS). Stroke 2003;34:1163–9.12702837
  5. Horne MA, Flemming KD, Su IC, Stapf C, Jeon JP, Li D, et al.; Cerebral Cavernous Malformations Individual Patient Data Meta-analysis Collaborators. Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data. Lancet Neurol 2016;15:166–73.26654287
  6. Josephson CB, Leach JP, Duncan R, Roberts RC, Counsell CE, Al-Shahi Salman R; Scottish Audit of Intracranial Vascular Malformations (SAIVMs) Steering Committee and Collaborators. Seizure risk from cavernous or arteriovenous malformations: prospective population-based study. Neurology 2011;76:1548–54.21536634
  7. Miller CE, Quayyum Z, McNamee P, Al-Shahi Salman R; Steering Committee SIVMS. Economic burden of intracranial vascular malformations in adults: prospective population-based study. Stroke 2009;40:1973–9.19359648
  8. Labauge P, Denier C, Bergametti F, Tournier-Lasserve E. Genetics of cavernous angiomas. Lancet Neurol 2007;6:237–44.17303530
  9. Bicalho VC, Bergmann A, Domingues F, Frossard JT, de Souza J. Cerebral cavernous malformations: patient-reported outcome validates conservative management. Cerebrovasc Dis 2017;44:313–9.28968597
  10. Moultrie F, Horne MA, Josephson CB, Hall JM, Counsell CE, Bhattacharya JJ, et al.; Scottish Audit of Intracranial Vascular Malformations (SAIVMs) Steering Committee and Collaborators. Outcome after surgical or conservative management of cerebral cavernous malformations. Neurology 2014;83:582–9.24994841
  11. Poorthuis MHF, Rinkel LA, Lammy S, Al-Shahi Salman R. Stereotactic radiosurgery for cerebral cavernous malformations: a systematic review. Neurology 2019;93:e1971–9.31659093
  12. Harris L, Poorthuis MHF, Grover P, Kitchen N, Al-Shahi Salman R. Surgery for cerebral cavernous malformations: a systematic review and meta-analysis. Neurosurg Rev 2022;45:231–41.34191202
  13. Poorthuis M, Samarasekera N, Kontoh K, Stuart I, Cope B, Kitchen N, Al-Shahi Salman R. Comparative studies of the diagnosis and treatment of cerebral cavernous malformations in adults: systematic review. Acta Neurochir (Wien) 2013;155:643–9.23371401
  14. Samarasekera N, Poorthuis M, Kontoh K, Stuart I, Respinger C, Berg J, et al. Guidelines for the Management of Cerebral Cavernous Malformations in Adults. UK: Genetic Alliance UK & Cavernoma Alliance; 2012.
  15. Akers A, Al-Shahi Salman R, A Awad I, Dahlem K, Flemming K, Hart B, et al. Synopsis of guidelines for the clinical management of cerebral cavernous malformations: consensus recommendations based on systematic literature review by the Angioma Alliance Scientific Advisory Board clinical experts panel. Neurosurgery 2017;80:665–80.28387823
  16. McGonigal A, Sahgal A, De Salles A, Hayashi M, Levivier M, Ma L, et al. Radiosurgery for epilepsy: systematic review and International Stereotactic Radiosurgery Society (ISRS) practice guideline. Epilepsy Res 2017;137:123–31.28939289
  17. Al-Shahi Salman R, Kitchen N, Thomson J, Ganesan V, Mallucci C, Radatz M; Cavernoma Priority Setting Partnership Steering Group. Top ten research priorities for brain and spine cavernous malformations. Lancet Neurol 2016;15:354–5.26831334
  18. Glasziou P, Chalmers I, Rawlins M, McCulloch P. When are randomised trials unnecessary? Picking signal from noise. BMJ 2007;334:349–51.17303884
  19. Poorthuis MH, Klijn CJ, Algra A, Rinkel GJ, Al-Shahi Salman R. Treatment of cerebral cavernous malformations: a systematic review and meta-regression analysis. J Neurol Neurosurg Psychiatry 2014;85:1319–23.24667206
  20. Rinkel LA, Al-Shahi Salman R, Rinkel GJ, Greving JP. Radiosurgical, neurosurgical, or no intervention for cerebral cavernous malformations: a decision analysis. Int J Stroke 2019;14:939–45.31122172
  21. Kivelev J, Niemela M, Kivisaari R, Dashti R, Laakso A, Hernesniemi J. Long-term outcome of patients with multiple cerebral cavernous malformations. Neurosurgery 2009;65:450–5; discussion 455.19687688
  22. Esposito P, Coulbois S, Kehrli P, Boyer P, Dietemann JL, Rousseaux P, et al. Place of the surgery in the management of brainstem cavernomas. Results of a multicentric study. Neurochirurgie 2003;49:5–12.12736575
  23. Mathiesen T, Edner G, Kihlstrom L. Deep and brainstem cavernomas: a consecutive 8-year series. J Neurosurg 2003;99:31–7.12854740
  24. Tarnaris A, Fernandes RP, Kitchen ND. Does conservative management for brain stem cavernomas have better long-term outcome? Br J Neurosurg 2008;22:748–57.19085358
  25. Huang AP, Chen JS, Yang CC, Wang KC, Yang SH, Lai DM, Tu YK. Brain stem cavernous malformations. J Clin Neurosci 2010;17:74–9.20005720
  26. Kida Y, Hasegawa T, Kato T, Sato T, Nagai H, Hishikawa T, et al. Natural history of symptomatic cavernous malformations and results of surgery. Jpn J Neurosurg 2015;24:108–18.
  27. Yoon PH, Kim DI, Jeon P, Ryu YH, Hwang GJ, Park SJ. Cerebral cavernous malformations: serial magnetic resonance imaging findings in patients with and without gamma knife surgery. Neurol Med Chir (Tokyo) 1998;38:255–61.10235015
  28. Lu XY, Sun H, Xu JG, Li QY. Stereotactic radiosurgery of brainstem cavernous malformations: a systematic review and meta-analysis. J Neurosurg 2014;120:982–7.24506243
  29. NHS England Clinical Reference Group for Stereotactic Radiosurgery. Clinical Commissioning Policy: Stereotactic Radiosurgery/Radiotherapy for Cavernous Venous Malformations (Cavernomas). 2013: NHS ENGLAND D05/P/g.
  30. Raymond J, Darsaut TE, Molyneux AJ; TEAM Collaborative Group. A trial on unruptured intracranial aneurysms (the TEAM trial): results, lessons from a failure and the necessity for clinical care trials. Trials 2011;12:64.21375745
  31. Mohr JP, Parides MK, Stapf C, Moquete E, Moy CS, Overbey JR, et al.; International ARUBA Investigators. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet 2014;383:614–21.24268105
  32. Magro E, Gentric JC, Darsaut TE, Ziegler D, Bojanowski MW, Raymond J. Responses to ARUBA: a systematic review and critical analysis for the design of future arteriovenous malformation trials. J Neurosurg 2017;126:486–94.27128584
  33. Donovan JL, Paramasivan S, de Salis I, Toerien M. Clear obstacles and hidden challenges: understanding recruiter perspectives in six pragmatic randomised controlled trials. Trials 2014;15:5.24393291
  34. Beasant L, Brigden A, Parslow RM, Apperley H, Keep T, Northam A, et al. Treatment preference and recruitment to pediatric RCTs: a systematic review. Contemp Clin Trials Commun 2019;14:100335.30949611
  35. Donovan JL, Rooshenas L, Jepson M, Elliott D, Wade J, Avery K, et al. Optimising recruitment and informed consent in randomised controlled trials: the development and implementation of the Quintet Recruitment Intervention (QRI). Trials 2016;17:283.27278130
  36. Donovan J, Mills N, Smith M, Brindle L, Jacoby A, Peters T, et al. Quality improvement report: improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. BMJ 2002;325:766–70.12364308
  37. Rooshenas L, Elliott D, Wade J, Jepson M, Paramasivan S, Strong S, et al.; ACST-2 Study Group. Conveying equipoise during recruitment for clinical trials: qualitative synthesis of clinicians’ practices across six randomised controlled trials. PLOS Med 2016;13:e1002147.27755555
  38. Paramasivan S, Huddart R, Hall E, Lewis R, Birtle A, Donovan JL. Key issues in recruitment to randomised controlled trials with very different interventions: a qualitative investigation of recruitment to the SPARE trial (CRUK/07/011). Trials 2011;12:78.21406089
  39. Rooshenas L, Scott LJ, Blazeby JM, Rogers CA, Tilling KM, Husbands S, et al.; By-Band-Sleeve Study Group. The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixedmethods evaluation. J Clin Epidemiol 2019;106:108–20.30339938
  40. CARE Pilot Trial Collaboration. Medical management and surgery versus medical management alone for symptomatic cerebral cavernous malformation (CARE): a feasibility study and randomised, open, pragmatic, pilot phase trial. Lancet Neurol 2024;23:565–76.38643777
  41. Wade J, Farrar N, Realpe AX, Donovan JL, Forsyth L, Harkness KA, et al. Addressing barriers and identifying facilitators to support informed consent and recruitment in the Cavernous malformations A Randomised Effectiveness (CARE) pilot phase trial: insights from the integrated QuinteT Recruitment Intervention (QRI). EClinicalMedicine 2024;71:102557.38813441
  42. Lorenc A, Rooshenas L, Conefrey C, Wade J, Farrar N, Mills N, et al. Non-COVID-19 UK clinical trials and the COVID-19 pandemic: impact, challenges and possible solutions. Trials 2023;24:424.37349850
  43. Flemming KD, Kim H, Hage S, Mandrekar J, Kinkade S, Girard R, et al. Trial readiness of cavernous malformations with symptomatic hemorrhage, Part I: event rates and clinical outcome. Stroke 2024;55:22–30.38134268
  44. Cenzato M, Sure U, Lanzino G, Boeris D, Meling T, Regli L, et al. Considerations for future trials in cerebral cavernous malformations. Lancet Neurol 2024;23:965.
  45. Alawieh AM, Saad H, Grossberg JA, Barrow DL. Considerations for future trials in cerebral cavernous malformations. Lancet Neurol 2024;23:964–5.39304256
  46. CARE Pilot Trial Collaboration. Considerations for future trials in cerebral cavernous malformations – authors’ reply. Lancet Neurol 2024;23:965–6.
  47. Flemming KD, Graff-Radford J, Aakre J, Kantarci K, Lanzino G, Brown RD, et al. Population-based prevalence of cerebral cavernous malformations in older adults: Mayo Clinic study of aging. JAMA Neurol 2017;74:801–5.28492932
  48. Venugopal V, Sumi S. Molecular biomarkers and drug targets in brain arteriovenous and cavernous malformations: where are we? Stroke 2022;53:279–89.34784742
  49. Gibson CC, Zhu W, Davis CT, Bowman-Kirigin JA, Chan AC, Ling J, et al. Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation. Circulation 2015;131:289–99.25486933
  50. Lanfranconi S, Scola E, Meessen JMTA, Pallini R, Bertani GA, Al-Shahi Salman R, et al.; Treat_CCM Investigators. Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial. Lancet Neurol 2023;22:35–44.36403580
  51. Zuurbier SM, Hickman CR, Tolias CS, Rinkel LA, Leyrer R, Flemming KD, et al.; Scottish Audit of Intracranial Vascular Malformations Steering Committee. Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis. Lancet Neurol 2019;18:935–41.31401075
  52. Zuurbier SM, Hickman CR, Rinkel LA, Berg R, Sure U, Al-Shahi Salman R; Scottish Audit of Intracranial Vascular Malformations Steering Committee and Collaborators. Association between beta-blocker or statin drug use and the risk of hemorrhage from cerebral cavernous malformations. Stroke 2022;53:2521–7.35410492
  53. Park JJH, Siden E, Zoratti MJ, Dron L, Harari O, Singer J, et al. Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols. Trials 2019;20:572.31533793
  54. Han RH, Johnson GW, Coxon AT, Gupta VP, Richards MJ, Lancia S, et al. Comparative effectiveness of management by surgical resection vs observation for cerebral cavernous malformations: a matched propensity score analysis. Neurosurgery Open 2022;3:e00011.
  55. Thompson D, Williams A, Hutchinson P, Helmy A, Cromwell D. A review of neurosurgical randomized controlled trials in the Cochrane Database of Systematic Reviews: key findings and implications for future research. World Neurosurg 2025;194:123471.39577644
← ConclusionsAdditional information →

Attribution. Rustam Al-Shahi Salman; Neil Kitchen; Laura Forsyth; Vijeya Ganesan; Peter S Hall; Kirsty Harkness et al. (2025). Medical management and intervention (using neurosurgical resection or stereotactic radiosurgery) versus medical management alone for symptomatic brain cavernoma: the CARE pilot RCT. National Institute for Health and Care Research. Copyright © 2025 Al-Shahi Salman et al. Licensed under CC BY 4.0. NCBI Bookshelf NBK617151. CC BY 4.0. Original source ↗. Text reproduced from the Bookshelf XML without changing wording; figures, images and supplements are not reproduced.

In this chapter Contents

  • References

Source

OpenStax source file ↗

Source record ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Rights and removal requests · Legal · Support